Class information for: |
Basic class information |
ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
---|---|---|---|
19372 | 444 | 41.7 | 87% |
Classes in level above (level 2) |
ID, lev. above |
Publications | Label for level above |
---|---|---|
1650 | 6377 | BICLUSTERING//PROGRAM TRANSLAT IMMUNOVIROL BIODEF//MAYO VACCINE GRP |
Terms with highest relevance score |
Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|---|
1 | PHILIP MORRIS INT RD | Address | 2 | 17% | 3% | 12 |
2 | COMPUTAT PL GENOM PROGRAM | Address | 2 | 67% | 0% | 2 |
3 | SECT COMPUTAT BIOMED | Address | 2 | 20% | 2% | 8 |
4 | BRONCHIAL AIRWAY EPITHELIUM | Author keyword | 1 | 50% | 0% | 2 |
5 | FIELD OF INJURY | Author keyword | 1 | 100% | 0% | 2 |
6 | LUNG CANCER DIAGNOSIS AND PROGNOSIS | Author keyword | 1 | 100% | 0% | 2 |
7 | PULM R3 | Address | 1 | 33% | 0% | 2 |
8 | AFFYMETRIX EXON ARRAYS | Author keyword | 1 | 50% | 0% | 1 |
9 | BENIGN BRONCHIAL EPITHELIUM | Author keyword | 1 | 50% | 0% | 1 |
10 | CARTES IDENTITE TUMEURS CIT PROGRAM | Address | 1 | 50% | 0% | 1 |
Web of Science journal categories |
Author Key Words |
Key Words Plus |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | SMALL AIRWAY EPITHELIUM | 3 | 50% | 1% | 4 |
2 | SIGNATURE PREDICTS SURVIVAL | 3 | 60% | 1% | 3 |
3 | EPITHELIAL GENE EXPRESSION | 2 | 33% | 1% | 6 |
4 | PROGNOSTIC SIGNATURES | 2 | 67% | 0% | 2 |
5 | EPITHELIAL CELL TRANSCRIPTOME | 1 | 50% | 0% | 2 |
6 | PROGNOSTIC CLASSIFIER | 1 | 50% | 0% | 2 |
7 | BRONCHIAL AIRWAY | 1 | 50% | 0% | 1 |
8 | CHERNOBYL THYROID CANCERS | 1 | 50% | 0% | 1 |
9 | DIAGNOSTIC REPRODUCIBILITY | 1 | 50% | 0% | 1 |
10 | EGFR MUTANT TUMORS | 1 | 50% | 0% | 1 |
Journals |
Reviews |
Title | Publ. year | Cit. | Active references |
% act. ref. to same field |
---|---|---|---|---|
Gene Expression Profiling for Early-stage NSCLC | 2015 | 1 | 38 | 71% |
Translating the transcriptome into tools for the early detection and prevention of lung cancer | 2015 | 2 | 34 | 38% |
Genomic medicine in non-small cell lung cancer: Paving the path to personalized care | 2011 | 9 | 66 | 48% |
An overview of lung cancer genomics and proteomics | 2005 | 81 | 61 | 34% |
Gene expression profiling reveals reproducible human lung adenocarcinoma subtypes in multiple independent patient cohorts | 2006 | 97 | 53 | 32% |
Gene expression profiling in lung cancer: Experimental research and clinical application | 2009 | 1 | 10 | 70% |
Commercially available prognostic molecular models in early-stage lung cancer: a review of the Pervenio Lung RS and Myriad myPlan Lung Cancer tests | 2015 | 0 | 30 | 53% |
Gene expression profiling on lung cancer outcome prediction: Present clinical value and future premise | 2006 | 19 | 28 | 50% |
Understanding Prognostic Gene Expression Signatures in Lung Cancer | 2009 | 12 | 66 | 39% |
Genomic Prognostic Models in Early-Stage Lung Cancer | 2009 | 12 | 71 | 38% |
Address terms |
Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | PHILIP MORRIS INT RD | 2 | 17% | 2.7% | 12 |
2 | COMPUTAT PL GENOM PROGRAM | 2 | 67% | 0.5% | 2 |
3 | SECT COMPUTAT BIOMED | 2 | 20% | 1.8% | 8 |
4 | PULM R3 | 1 | 33% | 0.5% | 2 |
5 | CARTES IDENTITE TUMEURS CIT PROGRAM | 1 | 50% | 0.2% | 1 |
6 | DOROTHY P RICHARD P SIMMONS INTERSTITIAL LUN | 1 | 50% | 0.2% | 1 |
7 | ENVIRONM GENET SECT | 1 | 50% | 0.2% | 1 |
8 | GEN GASTROINTESTINAL THORAC SURG | 1 | 50% | 0.2% | 1 |
9 | INGRAM COMPREHENS CANC | 1 | 50% | 0.2% | 1 |
10 | INTERNAL MED HUMAN GENET PUBL HLTH | 1 | 50% | 0.2% | 1 |
Related classes at same level (level 1) |
Rank | Relatedness score | Related classes |
---|---|---|
1 | 0.0000143383 | SW MED SIMMONS CANC//COPY NUMBER LOSS//K RAS GENOTYPES |
2 | 0.0000125213 | KIAA1199//MIR 188 5P//TRANSCRIPTOMIC PROFILES |
3 | 0.0000113582 | ERCC1//RRM1//MED OVARIAN CANC SECT |
4 | 0.0000102345 | GENE SET ANALYSIS//ENRICHMENT ANALYSIS//FUNCT GENOM NODE |
5 | 0.0000093910 | MICROARRAY IMAGE PROCESSING//GENE FILTERING//MAQC |
6 | 0.0000091882 | UNIT CLIN SYST BIOL//IN IDUALIZED MEDICAT//IN IDUALISED MED |
7 | 0.0000091762 | GENE SELECTION//FEATURE SELECTION//CANCER CLASSIFICATION |
8 | 0.0000091614 | ONCOTYPE DX//TRIPLE NEGATIVE BREAST CANCER//TRIPLE NEGATIVE |
9 | 0.0000086594 | N2 DISEASE//PLEURAL INVASION//STAGE IIIA |
10 | 0.0000083756 | BRONCHIOLOALVEOLAR CARCINOMA//BRONCHORRHEA//ATYPICAL ADENOMATOUS HYPERPLASIA |